Related Experiment Video
Updated: Jun 11, 2026
05:59
Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
Published on: December 4, 2015
2009 H1N1 influenza pandemic
1University of Portland, School of Nursing Kaiser Permanente, Portland, Oregon, USA. woot@up.edu
Summary
The 2009 H1N1 influenza pandemic highlighted the need for rapid vaccine development. Early vaccination against H1N1 influenza is critical for protecting children during the 2010-2011 flu season.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- The 2009 H1N1 influenza pandemic posed a significant threat, particularly to children and pregnant women.
- Rapid development of treatment guidelines and antiviral drug approvals were necessary.
- Prevention strategies, including vaccination and environmental controls, are crucial for child health.
Purpose of the Study:
- To summarize the public health response to the 2009 H1N1 influenza pandemic.
- To emphasize the importance of vaccination for children against H1N1 influenza.
- To inform about the inclusion of the 2009 H1N1 strain in the 2010-2011 seasonal influenza vaccine.
Main Methods:
- Review of public health responses and treatment guidelines.
- Monitoring of vaccine development and distribution timelines.
- Analysis of influenza virus activity and seasonal vaccine composition.
Main Results:
- A monovalent H1N1 vaccine was rapidly developed and distributed within five months.
- The 2009 H1N1 strain was incorporated into the 2010-2011 seasonal influenza vaccine.
- Predicting future H1N1 activity remains challenging.
Conclusions:
- Swift public health action was vital in managing the 2009 H1N1 pandemic.
- Timely vaccination of children with the updated seasonal influenza vaccine is essential for prevention.
- Continued vigilance and preparedness are necessary for future influenza seasons.
More Related Videos
05:21A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:51Vaccinations
Overview
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...